Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 14 studies | 34% ± 13% | |
macrophage | 10 studies | 23% ± 8% | |
classical monocyte | 7 studies | 27% ± 10% | |
microglial cell | 6 studies | 26% ± 10% | |
plasmacytoid dendritic cell | 6 studies | 23% ± 11% | |
squamous epithelial cell | 3 studies | 34% ± 18% | |
epithelial cell | 3 studies | 28% ± 8% | |
monocyte | 3 studies | 22% ± 7% | |
astrocyte | 3 studies | 20% ± 4% | |
oligodendrocyte | 3 studies | 16% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3326.23 | 180 / 180 | 100% | 15.58 | 430 / 430 |
breast | 100% | 2448.42 | 459 / 459 | 99% | 22.38 | 1112 / 1118 |
lung | 99% | 2334.90 | 575 / 578 | 100% | 21.38 | 1152 / 1155 |
thymus | 100% | 2225.73 | 651 / 653 | 99% | 33.29 | 601 / 605 |
esophagus | 99% | 1848.89 | 1432 / 1445 | 98% | 16.07 | 180 / 183 |
prostate | 99% | 1502.50 | 243 / 245 | 98% | 15.54 | 493 / 502 |
skin | 100% | 3587.14 | 1803 / 1809 | 97% | 25.41 | 460 / 472 |
uterus | 100% | 2544.29 | 170 / 170 | 97% | 15.67 | 444 / 459 |
bladder | 100% | 2594.86 | 21 / 21 | 96% | 13.27 | 484 / 504 |
stomach | 100% | 1893.60 | 359 / 359 | 95% | 14.46 | 273 / 286 |
brain | 95% | 1355.00 | 2511 / 2642 | 100% | 26.76 | 704 / 705 |
liver | 99% | 1174.99 | 224 / 226 | 95% | 11.81 | 385 / 406 |
adrenal gland | 98% | 1568.92 | 253 / 258 | 96% | 12.88 | 220 / 230 |
kidney | 99% | 1344.74 | 88 / 89 | 93% | 17.37 | 834 / 901 |
intestine | 99% | 2032.03 | 959 / 966 | 90% | 10.00 | 474 / 527 |
pancreas | 85% | 723.59 | 280 / 328 | 98% | 15.89 | 174 / 178 |
adipose | 100% | 2924.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7035.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2661.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.11 | 45 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 18.60 | 27 / 29 |
muscle | 89% | 785.09 | 717 / 803 | 0% | 0 | 0 / 0 |
heart | 88% | 982.34 | 758 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 10.29 | 70 / 80 |
peripheral blood | 78% | 2557.03 | 725 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015031 | Biological process | protein transport |
GO_2000786 | Biological process | positive regulation of autophagosome assembly |
GO_0016197 | Biological process | endosomal transport |
GO_0036089 | Biological process | cleavage furrow formation |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0006897 | Biological process | endocytosis |
GO_0097320 | Biological process | plasma membrane tubulation |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0005515 | Molecular function | protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
Gene name | SNX18 |
Protein name | Sorting nexin-18 (SH3 and PX domain-containing protein 3B) |
Synonyms | SH3PXD3B |
Description | FUNCTION: Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis . Required for efficient progress through mitosis and cytokinesis . Required for normal formation of the cleavage furrow at the end of mitosis . Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis . Plays a role in macropinocytosis . Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation . Stimulates the GTPase activity of DNM2 . Promotes DNM2 location at the plasma membrane . Together with DNM2, involved in autophagosome assembly by regulating trafficking from recycling endosomes of phospholipid scramblase ATG9A . . |
Accessions | Q96RF0 ENST00000343017.11 [Q96RF0-1] ENST00000381410.5 [Q96RF0-2] ENST00000326277.5 [Q96RF0-3] |